Universe Pharmaceuticals Inc

자세한 내용은 Universe Pharmaceuticals Inc 회사

Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.

회사 정보

종목 코드 UPC

회사 이름Universe Pharmaceuticals Inc

상장일Mar 23, 2021

CEOMr. Gang Lai

직원 수225

유형Ordinary Share

회계 연도 종료Mar 23

주소265 Jingjiu Avenue

도시JI'AN

증권 거래소NASDAQ Capital Market Consolidated

국가China

우편 번호343100

전화867968403309

웹사이트http://www.universe-pharmacy.com/

종목 코드 UPC

상장일Mar 23, 2021

CEOMr. Gang Lai

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Gang Lai

Chairman of the Board, Chief Executive Officer

--

Ms. Lin Yang

Chief Financial Officer, Director

--

Mr. Baochang Liu

Chief Operating Officer

--

Mr. Jiawen Pang

Independent Director

--

Mr. H. David Sherman

Independent Director

--

Mr. Ding Zheng

Independent Director

--

Ms. Tina Xiao

IR Contact Officer

--

이름

이름/직위

직위

주식 보유

변동

Mr. Gang Lai

Chairman of the Board, Chief Executive Officer

--

Ms. Lin Yang

Chief Financial Officer, Director

--

Mr. Baochang Liu

Chief Operating Officer

--

Mr. Jiawen Pang

Independent Director

--

Mr. H. David Sherman

Independent Director

--

Mr. Ding Zheng

Independent Director

--

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

Sales of TCMD products

14.03M

60.92%

Sales of third-party products

9.00M

39.08%

지역별USD

이름

수익

비율

China (Mainland)

23.02M

100.00%

사업별

지역별

사업별USD

이름

수익

비율

Sales of TCMD products

14.03M

60.92%

Sales of third-party products

9.00M

39.08%

주식 보유 통계

마지막 업데이트: Thu, May 15

주주

주주 유형

주주

비율

Sununion Holding Group Ltd

0.62%

UBS Financial Services, Inc.

0.05%

Other

99.34%

주주

비율

Sununion Holding Group Ltd

0.62%

UBS Financial Services, Inc.

0.05%

Other

99.34%

주주 유형

주주

비율

Corporation

0.62%

Investment Advisor

0.05%

Other

99.34%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

15

3.73K

0.66%

-14.56K

2025Q1

15

3.73K

8.84%

-14.56K

2024Q4

15

702.49K

4.61%

+518.42K

2024Q3

12

183.86K

3.78%

+44.54K

2024Q2

8

139.13K

0.94%

-3.04K

2024Q1

8

138.86K

57.13%

-3.66K

2023Q4

9

139.20K

57.27%

-3.80K

2023Q3

13

139.26K

57.29%

-143.15K

2023Q2

13

139.86K

57.87%

-142.30K

2023Q1

15

139.56K

57.75%

-143.20K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Sununion Holding Group Ltd

3.47K

0.62%

--

Apr 29, 2025

UBS Financial Services, Inc.

266.00

0.05%

+266.00

--

Mar 31, 2025

Sabby Management, LLC

--

0%

-8.33K

-100.00%

Mar 31, 2025

Anson Funds Management LP.

--

0%

-5.76K

-100.00%

Mar 31, 2025

Morgan Stanley & Co. LLC

--

0%

-2.00

-100.00%

Mar 31, 2025

MML Investors Services, LLC

--

0%

-390.00

-100.00%

Dec 31, 2024

Quadrature Capital LLP

--

0%

-41.00

-100.00%

Dec 31, 2024

Virtu Americas LLC

--

0%

-28.00

-100.00%

Dec 31, 2024

Geode Capital Management, L.L.C.

--

0%

-2.00

-100.00%

Oct 31, 2024

Two Sigma Investments, LP

--

0%

-151.00

-100.00%

Dec 31, 2024

3.395USD

Universe Pharmaceuticals Inc

3.395

개요

회사

금융